Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Hartford Post.
Press releases published on July 7, 2025
Pet Acoustics+ App Brings Science-Based Hearing and Stress Support to Dogs and Cats
EIN Presswire
·
July 7, 2025
Science meets comfort: Pet Acoustics+ helps pet parents soothe stress and protect hearing health with a simple, easy-to-use app. WASHINGTON DEPOT, CT, UNITED STATES, July 7, 2025 /EINPresswire.com/ -- In a first for pet wellness, Pet Acoustics Inc. has …
SKYRE Pioneers Breakthrough Technology to Unlock the Promise of Geologic Hydrogen
EIN Presswire
·
July 7, 2025
SKYRE's next-gen H2RENEW™ Gemini-1 Series is advancing clean energy production with cost-effective hydrogen recovery EAST HARTFORD, CT, UNITED STATES, July 7, 2025 /EINPresswire.com/ -- As the global race to tap geologic hydrogen heats up, SKYRE is …
Grayscale Investments® Announces Rebalancing of Multi-Asset Funds for Second Quarter 2025
GlobeNewswire
·
July 7, 2025
STAMFORD, Conn., July 07, 2025 (GLOBE NEWSWIRE) -- Grayscale Investments®, the world’s largest digital asset-focused investment platform, offering more than 30 crypto investment products, and manager of Grayscale® Decentralized Finance (DeFi) Fund (OTCQB: …
AC Reports Preliminary June 30 Book Value of $43.20 to $43.40 Per Share
GlobeNewswire
·
July 7, 2025
GREENWICH, Conn., July 07, 2025 (GLOBE NEWSWIRE) -- Associated Capital Group, Inc. (“AC” or the “Company”) (NYSE:AC), announced today a preliminary range for its second quarter book value of $43.20 to $43.40 per share. This compares to $42.51 per share at …
FuelCell Energy CEO Jason Few Applauds “One Big Beautiful Bill Act” as Catalyst for U.S. Clean Energy Leadership
GlobeNewswire
·
July 7, 2025
DANBURY, Conn., July 07, 2025 (GLOBE NEWSWIRE) -- FuelCell Energy, Inc. (Nasdaq: FCEL) President and CEO Jason Few has issued a statement praising the “One Big Beautiful Bill Act” (OBBBA) for its direct support of the fuel cell industry and its role in …
Abinopharm, Inc. and EGT Synbio Announce Successful Human Clinical Trials on Oral L-Ergothioneine (Dr.Ergo®) for Skin Health
GlobeNewswire
·
July 7, 2025
SHELTON, Conn., July 06, 2025 (GLOBE NEWSWIRE) -- Abinopharm, Inc., an innovative nutritional and biopharmaceutical company based in Shelton, Connecticut, USA, is pleased to announce that its partner, EGT Synbio, headquartered in Shanghai, China, has …